S, G., ES, N., D, T., R, S., L, D., & B, D. (2024). HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment. Frontiers in medicine, 10, 1288844. https://doi.org/10.3389/fmed.2023.1288844
Chicago Style (17th ed.) CitationS, Gandarillas, Newland ES, Toppmeyer D, Stephenson R, Denzin L, and Dasgeb B. "HLA Inherence as a Potential Parameter in Checkpoint Inhibitor-associated Autoimmune Adverse Event Assessment." Frontiers in Medicine 10 (2024): 1288844. https://doi.org/10.3389/fmed.2023.1288844.
MLA (9th ed.) CitationS, Gandarillas, et al. "HLA Inherence as a Potential Parameter in Checkpoint Inhibitor-associated Autoimmune Adverse Event Assessment." Frontiers in Medicine, vol. 10, 2024, p. 1288844, https://doi.org/10.3389/fmed.2023.1288844.